Zijie Li

机构：Zhengzhou University, Zhengzhou Children's Hospital · ORCID：0000-0002-1860-1029

发表论文 44 篇 · 总被引 508 次 · h-index 10

代表论文

• Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation (2024 · ACS Nano · 被引 37)
• Acidity-activatable dynamic hybrid nanoplatforms derived from extracellular vesicles of M1 macrophages enhance cancer immunotherapy through synergistic triple immunotherapy (2024 · Journal of Nanobiotechnology · 被引 25)
• Effectiveness of EV-A71 Vaccine and Its Impact on the Incidence of Hand, Foot and Mouth Disease: A Systematic Review (2024 · Vaccines · 被引 20)
• Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death (2024 · Life Sciences · 被引 19)
• Clinical and epidemiological characteristics of 96 pediatric human metapneumovirus infections in Henan, China after COVID-19 pandemic: a retrospective analysis (2024 · Virology Journal · 被引 19)
• Multi-omics analysis of host airway responses in pediatric Mycoplasma pneumoniae pneumonia reveals potential mechanisms of disease exacerbation caused by co-infection (2025 · npj Biofilms and Microbiomes · 被引 13)